67 results on '"Zolty, R."'
Search Results
2. (1003) Endomyocardial Biopsy Microscopic Molecular Profiling Correlates with Donor Derived Cell Free DNA and Histopathology
3. Impact of mTOR Inhibitor Conversion Protocol on Renal Function in Cardiac Transplant Recipients
4. Incidence of mTORi Associated BOOP in Cardiac Transplant Recipients – A Single Center Perspective
5. Sacubitril/Valsartan Improves Outcomes in Left Ventricular Assist Device Recipients
6. The Impact of Evolocumab in Cardiac Transplant Patients with Coronary Allograft Vasculopathy
7. Safety and Efficacy of SGLT2i Post Orthotopic Heart Transplantation
8. First Results of Soprano: Macitentan in Patients (pts) with Pulmonary Hypertension (PH) Post-Left Ventricular Assist Device (LVAD) Implantation
9. The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension
10. Pre-Heart Transplant Spirometry Predicts Post-Transplant Survival
11. Impact of Heart Rate and Left Ventricular Mass on Survival Following Heart Transplantation
12. Recurrent Pump Thrombosis is Common after Axial Continuous Flow LVAD Exchange
13. Comparison of Endothelin-1 Level in Group I Pulmonary Hypertension vs. Group II Pulmonary Hypertension Both at Rest and at Peak Exercise
14. Impact of Heart Rate and Left Ventricular Mass on Survival Following Heart Transplantation
15. Trends in Exercise Capacity Following Heart Transplantation
16. Pre-Operative Ventilatory Inefficiency is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
17. Pre-Operative Tricuspid Regurgitation and Right Ventricular Enlargement are Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
18. Cardiopulmonary Stress Test One Year After HTx Predicts the Development of CAV
19. Left Ventricular Assist Device Improves Type II Pulmonary Hypertension with High Pulmonary Vascular Resistance
20. Higher Heart Rate Is Associated with Lower Incidence of Coronary Allograft Vasculopathy Requiring Angioplasty
21. The Transmitral Peak Flow Velocity-Mitral Annular Diastolic Velocity Ratio (e/e') Does Not Predict Left Ventricular Filling Pressure Post Cardiac Transplant
22. Psychosocial Factors and Outcomes with Left Ventricular Assist Device Therapy
23. Depression in Patients Undergoing Left Ventricular Assist Device Implantation
24. Myocarditis Treated with VA-ECMO: A Single Centers Experience
25. Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients
26. Heart Failure Patients’ Quality of Life and Perception of Palliative Care
27. Cardiac Allograft Sinus Tachycardia Is Associated with Impaired Exercise Tolerance
28. CMV Reactivation Using Valganciclovir vs Valacyclovir in Moderate Risk Heart Transplant Recipients
29. Oxydative Stress in Heart Failure Patients after Implantation of Continuous Flow Left Ventricular Assist Devices
30. Heart Failure with Preserved Ejection Fraction Induced Reactive Pulmonary Hypertension Lacks Nitric Oxide Vasoreactivity Similar to Pulmonary Arterial Hypertension
31. Mineralocorticoid Receptor Antagonists Enhance Cardiac Function during Continuous Flow Left Ventricular Assist Device Support
32. Left Ventricular Internal Diastolic Diameter as a Predictor of Outcomes in Ischemic Cardiomyopathy
33. Differentiating Heart Failure with Preserved Ejection Fraction Induced Pulmonary Hypertension from Pulmonary Hypertension Using Demographic Data and Common Blood Measurements
34. Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin- Receptor Blockers (ARBs) during CF-LVAD Support Are Associated with Sustained Improvement in Renal Function
35. Intracranial Hemorrhage Is Associated with a Higher Doppler Blood Pressure during Continuous Flow Left Ventricular Assist Device Support
36. 819 Does a Low Ejection Fraction Predict Mortality? Insights From the ASCEND-HF Trial
37. 833 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
38. 838 Differences in Mortality and Morbidity in Pulmonary Hypertension Secondary to Systolic vs. Diastolic Heart Failure
39. 430 The Role of Cardiac Biomarkers in Takotsubo Cardiomyopathy
40. 621 Endothelin-1 Levels in Pulmonary Hypertension: A Comparison between Pulmonary Arterial Hypertension and Diastolic Heart Failure-Induced Pulmonary Hypertension
41. 616 Bradykinin Targeted Therapy Decreases Mortality in Pulmonary Hypertension
42. 499 Improved Survival with Statin Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
43. 21 Relaxin Levels Elevated in Patients with Pulmonary Arterial Hypertension
44. 310 Hypoalbuminemia Is a Predictor of Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
45. 309 Mortality in Pulmonary Hypertension Stratified by Sedimentation Rate
46. 678 Dose-Dependent Improvement in Survival with ACE Inhibitor Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
47. 504 Improved Survival with Pioglitazone in Patients with Diabetes Mellitus, Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction: A Comparative Effectiveness Analysis
48. 215 Higher Doses of Spirinolactone Are Associated with Lower Survival in Patients with Congestive Heart Failure
49. 503 Anti-Inflammatory Drugs Improve Mortality in Pulmonary Hypertension
50. 313 Effect of Nesiritide on Renal Function in Patients with Decompensated Diastolic Heart Failure Secondary to Pulmonary Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.